Live feed09:15:00·10mPRReleasevia QuantisnowGalmed Announces First Time Results in Prostate Oncology Studies: Aramchol Demonstrates 3-4 Fold Increase in Cell Death Compared to Enzalutamide (XTANDI®) Alone in Prostate Cancer ModelsByQuantisnow·Wall Street's wire, on your screen.GLMD· Galmed Pharmaceuticals Ltd.Health Care
